Holista Colltech Ltd

INVESTORS

Holista Colltech is a publicly listed company on the Australian Securities Exchange (ASX). Our issuer code is HCT.

All relevant announcements are posted in the securities exchange as required according to disclosure regulation. View latest announcements below.

For any questions regarding investors relation please email : investors@holistaco.com

ASX ANNOUNCEMENTS

2024 ASX Announcement

Date	Title
03 Apr 2024	Request for continued Voluntary Suspension
02 Apr 2024	Annual Report to shareholders
02 Apr 2024	Appendix 4G
21 Mar 2024	Suspension from Quotation
21 Mar 2024	Court Judgement and Board Changes
21 Mar 2024	Initial Director's Interest Notice
21 Mar 2024	Final Director's Interest Notice
29 Feb 2024	Appendix 4E - Preliminary Final Report
31 Jan 2024	Quarterly Activity and Cashflow Report

2023 ASX Announcement

Date	Title
08 Dec 23	Update on Federal Court Hearing
25 Oct 23	NASA Tech Co-Developed Supplements Launched in Malaysia
22 Sep 23	Holista Colltech Reaches Settlement with ASIC
20 Sep 23	Pause in Trading
20 Sep 23	Trading Halt
31 Aug 23	Appendix 4D - Half Year Report
05 Jul 23	Change in substantial holding
31 May 23	Results_of_Meeting_may23
31 May 23	AGM_Presentation
02 May 23	Notice of Annual General Meeting/Proxy Form
27 Apr 23	Quarterly Activity and Cash flow Report
06 Apr 23	Changes to the Board of Directors
06 Apr 23	Final Director's Interest Notice
06 Apr 23	Initial Director's Interest Notice
31 Mar 23	Appendix 4G
01 Mar 23	Becoming a substantial holder
28 Feb 23	Appendix 4E - Preliminary Final Report
31 Jan 23	Quarterly Activity and Cashflow Report

2022 ASX Announcement

Date	Title
07 Sep 2022	Supplementary Cleansing Prospectus
07 Sep 2022	Ceasing to be a substantial holder
06 Sep 2022	Cleansing Prospectus
06 Sep 2022	Notification regarding unquoted securities
30 Aug 2022	Record Interim Revenue and Improved Earnings
30 Aug 2022	Appendix 4D and Interim Financial Report
17 Aug 2022	Application for quotation of securities
17 Aug 2022	Proposed issue of securities
04 Aug 2022	Investor Webinar Presentation
28 Jul 2022	Quarterly Activity and Cashflow Report
24 Jun 2022	Application for quotation of securities - HCT
24 Jun 2022	Becoming a substantial holder
31 May 2022	Results of Meeting
31 May 2022	AGM Presentation
29 Apr 2022	Letter to Shareholders
29 Apr 2022	Notice of Annual General Meeting/Proxy Form
29 Apr 2022	Quarterly Activity and Cashflow Report
29 Apr 2022	Test Results on All-Natural Nano Silver Disinfectant
21 Apr 2022	First Commercial Order from Country Farms / Starbucks
31 Mar 2022	Appendix 4G
31 Mar 2022	Annual Report to shareholders
28 Feb 2022	Appendix 4E - Preliminary Final Report
28 Jan 2022	Investor Presentation
28 Jan 2022	Quarterly Activity Report and Appendix 4C

2021 ASX Announcement

Date	Title
12 Nov 2021	Investor Presentation
01 Nov 2021	Quarterly Report Clarification
29 Oct 2021	Quarterly Activity Report and Appendix 4C
29 Oct 2021	Natshield Test Results
12 Oct 2021	Holista Signs Term Sheet with Berjaya Country Farms
12 Oct 2021	Trading Halt
12 Oct 2021	Pause in Trading
20 Sept 2021	Natshield Receives Trademark Approval for Sales in China
01 Sept 2021	Change of Company Secretary and Registered Office
27 Aug 2021	Appendix 4D and Interim Financial Report
27 Aug 2021	Holista Delivers Improved Interim Revenue and Profit
27 Aug 2021	Pause in Trading
05 Aug 2021	Court Proceeding
04 Aug 2021	Trading Halt
04 Aug 2021	Final Director's Interest Notice
04 Aug 2021	Initial Director's Interest Notice
30 Jul 2021	Results of 2021 Annual General Meeting
30 Jul 2021	Board Changes
30 Jul 2021	AGM Presentation
28 Jul 2021	Quarterly Activities Report and Appendix 4C
09 Jul 2021	Results of Share Sale Facility for Unmarketable Parcels
30 Jun 2021	Notice of Annual General Meeting / Proxy Form
28 Jun 2021	Final Director's Interest Notice
28 Jun 2021	Final Director's Interest Notice
28 Jun 2021	Initial Director's Interest Notice
28 Jun 2021	Board Changes
23 Jun 2021	Update on Legal Dispute
18 Jun 2021	Maiden Order for SARS-CoV-2 test kits in Malaysia
26 May 2021	Reinstatement to Official Quotation
26 May 2021	State Grant Secured to Produce Medical Grade Collagen
26 May 2021	Collagen Market Update - Further Information
25 May 2021	Extension of existing voluntary suspension
24 May 2021	Extension of existing voluntary suspension
20 May 2021	Extension of existing voluntary suspension
17 May 2021	Suspension from Official Quotation
13 May 2021	Trading Halt
13 May 2021	Pause in Trading
13 May 2021	Collagen Market Update
10 May 2021	Unmarketable Parcels
29 Apr 2021	Appendix 4C - quarterly
23 Apr 2021	Legal Dispute
23 Apr 2021	Pause in Trading
12 Apr 2021	Investor Presentation - April 2021
06 Apr 2021	Appendix 4G
31 Mar 2021	Notice of change of interests of substantial holder
26 Feb 2021	Holista posts resilient FY revenue and Positive 2021 outlook
26 Feb 2021	Appendix 4E Preliminary Final Report
27 Jan 2021	Holista Colltech Appendix 4C and Quarterly Update

2020 ASX Announcement

Date	Title
11 Dec 2020	Reinstatement to Official Quotation
11 Dec 2020	Holista to Launch 'List N' Disinfectant
10 Dec 2020	Suspension from Official Quotation
08 Dec 2020	Trading Halt
08 Dec 2020	Pause in Trading
27 Nov 2020	HCT Advances TGA Application on NatShield COVID-19 Labelling
18 Nov 2020	Holista Receives First Orders from Costanzo's for US Launch
26 Oct 2020	Appendix 4C Quarterly Cashflow Report and Commentary
21 Oct 2020	Response to ASIC Decision
21 Oct 2020	Pause in Trading
19 Oct 2020	GICC US Test - MicroBac for Path-Away
19 Oct 2020	Successful Testing of Path-Away Against SARS-CoV-2
16 Oct 2020	Holista Terminates Term Sheet with Skin Elements
14 Oct 2020	Trading Halt
01 Oct 2020	US Sales Secured for World's Lowest GI Clean Label Bread
14 Sep 2020	Holista Opens Subsidiary and Enters Strategic Partnership
14 Sep 2020	Reinstatement to Official Quotation
14 Sep 2020	Proposed issue of Securities - HCT
14 Sep 2020	Suspension from Official Quotation
10 Sep 2020	Pause in Trading
02 Sep 2020	JV for the production of M3 HVAC systems
02 Sep 2020	Pause in Trading
01 Sep 2020	Change of Director's Interest Notice
01 Sep 2020	Appendix 3G
28 Aug 2020	Response to ASX Aware Query
28 Aug 2020	Appendix 4D and Interim Financial Report 2020
20 Aug 2020	Response to ASX Aware Letter
14 Aug 2020	Response to ASX Aware Letter
13 Aug 2020	Final Director's Interest Notice
13 Aug 2020	Initial Director's Interest Notice
11 Aug 2020	Change of Director and Company Secretary
10 Aug 2020	New Constitution
31 Jul 2020	Results of Annual General Meeting
31 Jul 2020	AGM Presentation
30 Jul 2020	Appendix 4C Quarterly Cashflow Report and Commentary
20 Jul 2020	Addendum to 2020 Notice of Annual General Meeting
13 Jul 2020	Response to ASX Aware Query
13 Jul 2020	Change of Company Secretary and Registered Office
09 Jul 2020	Update on Sales and Distribution Agreements for Natshield
09 Jul 2020	Pause in Trading
07 Jul 2020	Final Director's Interest Notice
07 Jul 2020	Initial Director's Interest Notice
02 Jul 2020	Board Changes
30 Jun 2020	Letter to shareholders - Notice of AGM
30 Jun 2020	Notice of Annual General Meeting
12 Jun 2020	Proposed issue of Securities
12 Jun 2020	Protectene acquired to add advanced skin ingredient
03 Jun 2020	Tortilla successfully tested as low-GI by Sydney University
12 May 2020	Appointment of UK Distributor for Natshield Sanitiser
08 May 2020	Global Patent filed for Natshield Nasal Sanitising Balm
07 May 2020	Natshield to be trialled by intelligent sterilisation robots
29 Apr 2020	Appendix 4C Quarterly Cashflow Report and Commentary
21 Apr 2020	Clarification - Acceleration of Natshield - Raising $2.2M
20 Apr 2020	Controlled Placement Agreement Share Issue
20 Apr 2020	Retraction of statement made on Twitter
20 Apr 2020	Pause in trading
20 Apr 2020	Successful UK Lab tests
20 Apr 2020	Response to ASX Aware Query
16 Apr 2020	Trading Halt
09 Apr 2020	Change of Directors Interest Notice
09 Apr 2020	US Distributor increases order of Natshield to $3.8M
08 Apr 2020	Achievement of Performance Rights Milestones
08 Apr 2020	Appendix 2A
03 Apr 2020	Binding agreement with Skin Elements to launch sanitiser
31 Mar 2020	Appendix 4G - Corporate Governance
19 Mar 2020	US Distributor for Natshield sanitiser appointed with sales
16 Mar 2020	Commencement of tests in UK Lab of Pathaway
11 Mar 2020	Maiden Sales of $1.4M for 80Less Sugar Formulation
04 Mar 2020	S708 Cleansing Notice
04 Mar 2020	Appendix 2A
04 Mar 2020	Controlled Placement Agreement Share Issue
03 Mar 2020	Letter of confirmation towards global distribution rights
28 Feb 2020	Appendix 4E Preliminary Final Report
27 Feb 2020	Dr Arthur Martin joins Scientific Advisory Board
27 Feb 2020	Initial Director's Interest Notice
25 Feb 2020	Retraction of Statements and Clarification
21 Feb 2020	Trading Halt
21 Feb 2020	Pause in Trade
21 Feb 2020	Appointment of Non-executive Chairman and Company Secretary
20 Feb 2020	Holista Colltech & GICC LLC Collaboration Presentation
20 Feb 2020	HCT to Co-Develop Nasal Sanitising Balm and Extend NatShield
20 Feb 2020	S708 Cleansing Notice
20 Feb 2020	Appendix 2A
19 Feb 2020	Response to ASX Price and Volume Query
19 Feb 2020	Controlled Placement Agreement Share Issue
11 Feb 2020	S708 Cleansing Notice
11 Feb 2020	Appendix 2A
11 Feb 2020	Controlled Placement Agreement & Share Issue
10 Feb 2020	Increase in shipments for Natshield and Aust bottling plans
06 Feb 2020	Natshield Nasal Balm with Path-Away as Viruses Barrier
30 Jan 2020	Appendix 4C Quarterly Report and Quarterly Review
30 Jan 2020	Response to Article in the West Australian newspaper
30 Jan 2020	Trading Halt Request
30 Jan 2020	Trading Halt
30 Jan 2020	Pause in Trading
29 Jan 2020	Natshield Sanitizer Orders Spike On Coronavirus Outbreak
13 Jan 2020	HCT- Controlled Placement Extension

2019 ASX Announcement

Date	Title
12 Dec 2019	HCT Files Patent for Water-Soluble Cannabidiol Technology
12 Dec 2019	Specifications - Patent for Water-Soluble Cannabidiol Technology
12 Dec 2019	Drawing - Patent for Water-Soluble Cannabidiol Technology
12 Dec 2019	Bio - Dr Roscoe Moore
12 Dec 2019	Bio - Dr Swanand Malode
27 Nov 2019	Regulatory Clearance Received and Appointment of Distributor
05 Nov 2019	Holista Subsidary Wins Award for Two Low-GI Pastas
31 Oct 2019	Appendix 4C Quarterly Report and Quarterly Review
16 Oct 2019	Holista to Co-Develop Healthy Bubble Tea Ingredients
09 Oct 2019	Flatbreads succcessfully tested as low-GI by University of Sydney
16 Sep 2019	2019 China Low-GI Conference Presentation
03 Sep 2019	Maiden Low-GI Ingredient Shipment to Malaysian Manufacturer
30 Aug 219	Appendix 4D and Interim Financial Report 2019
26 Aug 2019	South Korea Approve Low-GI Noodles, First Order Received
14 Aug 2019	Announcement by Singapore eDevelopment Limited
30 Jul 2019	Holista Commences Low-GI Noodle Bulk Shipment to China
30 Jul 2019	Appendix 4C Quarterly Report and Quarterly Review
30 May 2019	Results Of Meeting
30 May 2019	HCT AGM 2019 Presentation
30 Apr 2019	Appendix 4C Quarterly Report and Quarterly Review 31 Mar 19
26 Apr 2019	Notice of Annual General Meeting and Proxy Form
05 Apr 2019	Appendix 4G
29 Mar 2019	Annual Report to shareholders
28 Feb 2019	Appendix 4E Preliminary Final Report
14 Feb 2019	Holista Announces 80LESS Low-Calorie Sugar Reformulation
13 Feb 2019	Response to ASX Appendix 3Y Query
13 Feb 2019	Response to ASX Appendix 4C Query
08 Feb 2019	Change of Directors Interest Notice
25 Jan 2019	Appendix 4C Quarterly Report - 31 Dec 18
16 Jan 2019	Holista and Kawan to Develop Breakthrough Low Gi Roti Canai
10 Jan 2019	Holista Secures North American Distribution Rights

2018 ASX Announcement

Date	Title
11 Dec 2018	Launch of Low-GI Past
26 Nov 2018	Appointment of Distributor for Low-GI Pasta for Canada
30 Oct 2018	Appendix 4C Quarterly Report - 30 Sep 18
18 Oct 2018	Appendix 3B
31 Aug 2018	Half Yearly Report and Accounts
13 Aug 2018	Change of Director's Interest Notice
06 Aug 2018	HCT Successfully Completes Underwitten Share Purchase Plan
06 Aug 2018	Cleansing Notice and Appendix 3B
30 Jul 2018	Results of Meeting
27 Jul 2018	Appendix 4C and Quarter Update - 30 Jun 18
20 Jul 2018	Holista Extends Food Ingredient Offering in USA and Canada
05 Jul 2018	Holista Signs Agreement to Export Low-GI Noodles to China
27 Jun 2018	Notice of General Meeting / Proxy Form
26 Jun 2018	Invitation to participate in share purchase plan
26 Jun 2018	Holista Colltech Limited Cleansing Notice
25 Jun 2018	HCT Clean-Label Low-GI Noodles Now Sold on Amazon.com
22 Jun 2018	Holista Colltech Limited Share Purchase Plan
31 May 2018	Results of Annual General Meeting
22 May 2018	Response to ASX Query
02 May 2018	Notice_of_Annual_General_Meeting_Proxy_Form
20 Apr 2018	HCT - Low GI Sugar Patent - Clarification of Announcements Amended
19 Apr 2018	Appendix 4C - quarterly 31 Mar 18
06 Apr 2018	Low GI Sugar Patent - Clarification of Announcements
29 Mar 2018	Appendix 4G
22 Mar 2018	First Shipment of 1000kg of GI Reducer Formula to Canada
28 Feb 2018	Appendix 4E Preliminary Final Report 31 Dec 2017
28 Feb 2018	Announcement by Global Biolife Successful Testing Vs Ebola
22 Feb 2018	Holista Secures First Confirmed Order To Supply Patented Mix For Low-GI Noodles
20 Feb 2018	Q&A Update on Low GI White Bread
14 Feb 2018	HCT Signed US$6M MOU With Wings Canada
09 Feb 2018	Appendix 3B
09 Feb 2018	Cleansing Notice
07 Feb 2018	Controlled Placement Agreement
31 Jan 2018	Appendix 4C Qtr - 31 Dec 17
23 Jan 2018	Change of Joint Company Secretary
11 Jan 2018	Announcement By Global Biolife Inc.

2017 ASX Announcement

Date	Title
27 Nov 2017	HCT To Co-Develop Advanced GI Screening Methods With FIAL
14 Nov 2017	HCT Secures Global Rights To Distribute Stem Cell Supplement
26 Oct 2017	Appendix 4C Qtr
25 Oct 2017	Announcement by Global Biolife Inc
24 Oct 2017	Appendix 3B
19 Oct 2017	Development of Breakthrough Noodle Formula with Low GI
06 Oct 2017	Appendix 3B and Change of Director's Interest Notice
28 Sep2017	Follow up Q & A to announcement on 21 Sep 2017
27 Sep 2017	Appendix 3B and Change of Director's Interest Notice
21 Sep2017	HCT Acquires 47% Stake In iGalen
19 Sep 2017	Trading Halt
31 Aug 2017	Half Yearly Report and Accounts
28 Aug 2017	Follow up Q&A to announcement on 21 Aug 2017 (Food-Grade Collagen)
21 Aug 2017	Facility to Produce Halal Food-Grade Sheep Collagen
18Aug2017	Annoucement by Global BioLife Inc
09 Aug2017	Holista Secures Global Rights For EMULIN
01 Aug 2017	Appendix 3B
31 Jul 2017	Appendix 4C - Qtr 30Jun17
28 Jun 2017	Appendix 3B
19 Jun 2017	Appendix 3B / Change of Director's Interest Notice
30 May 2017	Change of Director's Interest Notice
25 May 2017	Appendix 3B
22 May 2017	Announcement by Global BioLife Inc.
18 May 2017	Results of Meeting
27 Apr 2017	Appointment of Joint Company Secretary
27 Apr 2017	Appendix 4C Jan-Mar 2017
19 Apr 2017	Appendix 3B / Change of Director's Interest Notice
18 Apr 2017	Notice of Annual General Meeting/Proxy Form
04 Apr 2017	Appendix 4G
03 Apr 2017	HCT to supply medical grade collagen to Keneric Medical
27 Mar 2017	Appendix 3B / Change of Director's Interest Notice
23 Mar 219	Appendix 3B
31 Jan 2017	Change of Directors Interest Notice
24 Jan 2017	Appendix 4C Oct-Dec 16
16 Jan 2017	Follow up Q&A to HCT Announcement on 6 Jan 17
09 Jan 2017	Change of Financial Year End to 31 Dec
09 Jan 2017	Results of Meeting
	Appendix 4E Preliminary Final Report 31Dec 16

2016 ASX Announcement

Date	Title
21 Dec 2016	Change of Address
12 Dec 2016	GI Reducer Formulae Successfully Tested By University of Sydney
15 Nov 2016	Carried Interest in SED BIOMEDICAL INC.
28 Oct 2016	Appendix 4C Jul-Sep 2016
21 Oct 2016	Low GI Noodles
30 Sep 2016	Appendix 4G
31 Aug 2016	Appendix 4E-30 Jun 2016 (Preliminary)
28 Jul 2016	Appendix 4C Quarterly Report Ended 30 Jun 2016
12 Jul 2016	Holista Sets Up Joint Venture To Promote Low-GI White Bread
12 May 2016	Response to ASX Price Query
29 Apr 2016	Appendix 3B & Change of Directors Interest Notice
28 Apr 2016	Appendix 4C Quarterly Report Ended 31 Mac 2016
11 Apr 2016	Appendix 3B & Change of Directors Interest Notice
06 Apr 2016	North America, Extending Partnership With HCT
03 Mar 2016	Healthy LOW-GI Muffins for US and CANADIAN Market
19 Feb 2016	Opportunity to Meet with HCT CEO & Mr Meiert Grootes
16 Feb 2016	Placement to Major Shareholder of Swiss Panadoro Group
27 Jan 2016	Low GI Bread Update
12 Jan 2016	Global Scientific Breakthrough

2015 ASX Announcement

Date	Title
24 Nov 2015	Results of AGM
29 Oct 2015	Appendix 4C Quarter ended 30 Sept 2015
29 Oct 2015	Appendix 3B - Change of Director's Interest Notice
23 Oct 2015	Proposed Change in Substantial Holder
23 Oct 2015	Notice of AGM
7 Oct 2015	Appendix 4G
28 Aug 2015	Appendix 4E-30 Jun 2015 (Preliminary)
29 Jul 2015	Appendix 4C Quarterly report ends 30 Jun 2015
16 Jun 2015	Partnership Signed to Prevent Counterfeit of HCT Products
16 Jun 2015	Launch of Herring Caviar Fish Oil in Asia
29 Apr 2015	Acquisition Of Asia Pacific Rights For Geltox
29 Apr 2015	Appendix 4C Quarterly report ends 31 Mac 2015
09 Mar 2015	First Global Customer For Food Grade Sheep Collagen
23 Feb 2015	World's first food grade sheep collagen
05 Feb 2015	Exclusive Supply Arrangement - Multi level Marketing Company
02 Feb 2015	Holista acquires the Asian rights of emulin
02 Feb 2015	Appendix 4C Quarterly report end 31 dec 2014

2014 ASX Announcement

Date	Title
27 Nov 2014	Result of Annual General Meeting
28 Oct 2014	Appendix 4C - Quarter ended 30 Sept 2014
28 Oct 2014	Notice Of AGM
30 Jun 2014	Appendix 4E Preliminary Final Report
30 Jun 2014	Appendix 4C - guarter end Jun
30 Jun 2014	Results of General Meeting
27 May 2014	Notice of General Meeting
28 Apr 2014	Appendix 4C - quarterly end Mar
28 Feb 2014	Appendix 4D and Interim Financial Report
28 Feb 2014	Change of Registered Office and Contact Numbers
28 Jan 2014	Appendix 4C - quarterly end Dec

2013 ASX Announcement

Date	Title
18 Dec 2013	Appendix 3Y and Appendix 3B
18 Dec 2013	Notice of change of interests of substantial holder
27 Nov 2013	Results of Annual General Meeting
13 Nov 2013	Roscoe Moore
08 Nov 2013	Corporate and Business Update
25 Oct 2013	Notice of Annual General Meeting
14 Oct 2013	Annoucement on LiteFood
08 Oct 2013	Holista Co-Develops 80LESS
01 Oct 2013	HCT Signs Agreement with Switzerland's Veripan
31 Jul 2013	Resignation of Director
01 Jul 2013	Appendix 3X - Initial Director's Interest Notice
01 Jul 2013	Convertible Loan Agreement & Appointment of Director

2012 ASX Announcement

Date	Title
21 Nov 2012	Results of Annual General Meeting
12 Nov 2012	Sale of Idle Vacant Industrial Land In Malaysia
17 Oct 2012	Notice of Annual General Meeting
03 Oct 2012	Director Resignation & Appendix 3Z
19 Sep 2012	Exclusive Distribution Agreement for Ovine Collagen
01 Aug 2012	Initial Director's Interest Notice
01 Aug 2012	Appointment of Chairman
15 May 2012	Market Update-Food Grade Collagen
04 May 2012	Appointment of Executive Director
30 Apr 2012	Market Update Collagen
08 Mar 2012	Change of Registered Office and Contact Details
31 Jan 2012	Change of Director's Interest Notice
31 Jan 2012	Change of Company Office holders

2011 ASX Announcement

Date	Title
02 Dec 2011	Change of contact and office details
29 Nov 2011	Results of Meeting AGM
29 Nov 2011	Board Changes Appendix 3X & 3Z
29 Nov 2011	Chairman Address to AGM 29 Nov2011
07 Nov 2011	HCT QSRH agreement
07 Nov 2011	Voluntary suspension request
	ESOP
04 Oct 2011	2011-22 - App3x BenDonovan
04 Oct 2011	Appointment Of Ben Donovan As Interim Director
09 Aug 2011	2011-15 HCT Malaysia Mousticide Registation
25 Jul 2011	2011-14 HCT Nano Collagen
07 Jul 2011	2011-12 Indian Joint Venture
27 Jun 2011	Collagen Update
16 May 2011	Change of Auditor
02 May 2011	Appointment of Chairman
04 Apr 2011	Initial Director's Interest Notice
04 Apr 2011	Final Director's Interest Notice
04 Apr 2011	Board Changes
31 Jan 2011	Patent Lodged - Low Sodium Salt, Low GI and Low Fat Chips
04 Jan 2011	Policy for trading in company securities

2010 ASX Announcement

Date	Title
14 December 2010	Change of Director's Interest Notice
23 November 2010	Final Director's Interest Notice.Mr Govindan
23 November 2010	Final Director's Interest Notice - Mr Pixley
23 November 2010	Results of Annual General Meeting
23 November 2010	AGM Presentation
23 November 2010	CEO Remarks for AGM
02 November 2010	Media Release R&D and Commercial Launch of First Halal Ovine Collagen
25 October 2010	Media Release ASX Listed Holista Develops Halal Food Grade Sheep Collagen
15 October 2010	Notice of Annual General Meeting
15 October 2010	Initial Directors Interest Notice
15 October 2010	Appointment of Dr Stuart Hazell
01 October 2010	Annual Reports 30 June 2010
29 September 2010	Professor Henry wins Two Major Awards
07 September 2010	APPOINTMENT OF CEO
31 August 2010	Appointment of Scientific Board
14 July 2010	New Issue Announcement
25 June 2010	Release from ESCROW
07 May 2010	Change of Registered Office
01 March 2010	Half Year Report Period Ended 31 December 2009
11 February 2010	Amended Quarterly Report
29 January 2010	Quarterly report for entities admitted on the basis of commitments
21 January 2010	Patent Granted in Taiwan
18 January 2010	Appointment to Scientific Advisory Board

2009 ASX Announcement

Date	Title
24 November 2009	Change of Director's Interest Notice
20 November 2009	Appointment of Company Secretary
20 November 2009	Appendix 3Y - Change of Director's Interest Notice
16 November 2009	Appendix 3B New Issue Announcement
13 November 2009	Final Director's Interest Notice
11 November 2009	Address by Dato Dr Rajen at AGM
11 November 2009	Annual General Meeting Results
4 November 2009	Appendix 3B - New Issue Announcement
30 October 2009	Appendix 4C - Quarterly report
13 October 2009	Section 708A 5 of the Corporation Act
13 October 2009	Notice of Annual General Meeting
13 October 2009	Placement
1 October 2009	Letter to Option Holders
24 September 2009	HCT's Ovine Collagen used in USA Research Program
22 September 2009	HCT positions itself for Halal Ovine Collagen
16 September 2009	Placement undertaken for AUD2.5 m
7 September 2009	Appointment as Exclusive Distributor - Larvacide
7 August 2009	Initial Director's Interest Notice

COMPANY UPDATES

2021 Updates

Date	Title
18 Mar 2021	World’s First Low GI ‘Clean Label’ Bread
07 Jan 2021	Presention to the MOH

2020 Updates

Date	Title
07 Sep 2020	Natshield™ Flyer
07 Sep 2020	Session Report Rethinking Healthcare
20 Jun 2020	Pandemic Protection
15 Jun 2020	The Motley Fool ~ Why the Holista CollTech share price is climbing higher today
15 Jun 2020	MSN ~ Why the Holista CollTech share price is climbing higher today
07 Jun 2020	Statement on the Use of a Coronavirus Surrogate in Virology Testing by MSL
28 May 2020	Statement By Senior Scientific Advisor
26 May 2020	Appointment Of Distributor Of Natshield

ANNUAL REPORTS

Annual Report 2022

Annual Report 2021

Annual Report 2020

Annual Report 2019

Annual Report 2018

Annual Report 2017

Annual Report Dec 2016

Annual Report Jun 2016

Annual Report 2015

Annual Report 2014

Annual Report 2013

Annual Report 2012

Annual Report 2011

Annual Report 2010

Annual Report 2009

Annual Report 2008

Annual Report 2007

Annual Report 2006

Annual Report 2005

Annual Report 2004

CORPORATE GOVERNANCE

At Holista Colltech we are committed to a high standard of corporate governance that will eventually enhance shareholders values. We adheres to all corporate governance value with the aim of ensuring transparency and accountability.

Announcements and Policies

Title
Corporate Governance Plan 4th Edition Compliant

CORPORATE INFORMATION

At Holista Colltech we are committed to a high standard of corporate governance that will eventually enhance shareholders values. We adheres to all corporate governance value with the aim of ensuring transparency and accountability.

Corporate directory